BDX 3.57% 14.5¢ bcal diagnostics limited

Ann: Half Yearly Report and Accounts, page-4

  1. 27,181 Posts.
    lightbulb Created with Sketch. 3172
    When you discover something with the earnings potential like this,

    lets say a profit $?? from test (out of 350 cost) ??? Theres going to be a margin in there somewhere.
    They dont just supply the test at cost basis.

    Anyway, thats a volume target market in AUS of 900k pa who get mams,(and 27m in the USA) - now who that is health conscious enough to sit through a mam, wouldnt also give a blood sample if it was more sensitive ? Add all the others in a growth market would would just do it at the behest of their GP check up every now and then ?

    Also consider the possible increase risk that some may now potentially face, video link below mentions impairment of P53 cancer defender genomes (skin and renal, and a few others) and BRCA ( breast, ovarian and a few other female reproductive) from your not so safe, nor fully tested genetic product. (that skipped cancer and genotoxicity studies prior to mass release).
    Last edited by stevenjd: 26/02/24
 
watchlist Created with Sketch. Add BDX (ASX) to my watchlist
(20min delay)
Last
14.5¢
Change
0.005(3.57%)
Mkt cap ! $45.57M
Open High Low Value Volume
14.0¢ 14.5¢ 13.5¢ $11.59K 81.57K

Buyers (Bids)

No. Vol. Price($)
5 105524 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
14.5¢ 102787 2
View Market Depth
Last trade - 12.05pm 08/07/2024 (20 minute delay) ?
BDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.